Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “B-Cell Lymphoma Stage I”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01381692
What this trial is testing

Bortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma

Who this might be right for
Recurrent Follicular LymphomaRecurrent Mantle Cell LymphomaRecurrent Marginal Zone Lymphoma+8 more
National Cancer Institute (NCI) 9
Not applicableUnknownNCT00400907
What this trial is testing

Observation in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Treated on Clinical Trial CAN-NCIC-LY9

Who this might be right for
Long-term Effects Secondary to Cancer Therapy in AdultsLymphoma
German High-Grade Non-Hodgkin's Lymphoma Study Group 667
Early research (Phase 1)Ended earlyNCT02706392
What this trial is testing

Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmMetastatic Lung Non-Small Cell Carcinoma+10 more
Fred Hutchinson Cancer Center 21
Early research (Phase 1)Ended earlyNCT05515406
What this trial is testing

Investigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLL

Who this might be right for
Lymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-Cell
Ono Pharmaceutical Co., Ltd. 9
Testing effectiveness (Phase 2)WithdrawnNCT06005649
What this trial is testing

Clinical Trial of HY004 Cell Injection in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-hodgkin Lymphoma
Juventas Cell Therapy Ltd.
Early research (Phase 1)WithdrawnNCT03807063
What this trial is testing

Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell Transplant

Who this might be right for
Acute Bilineal LeukemiaMyelodysplastic/Myeloproliferative NeoplasmMyelodysplastic/Myeloproliferative Neoplasm, Unclassifiable+9 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Active Not RecruitingNCT04684563
What this trial is testing

HuCART19-IL18 in CD19+ Cancers

Who this might be right for
Chronic Lymphocytic LeukemiaNon-hodgkin LymphomaAcute Lymphoblastic Leukemia
University of Pennsylvania 72
Early research (Phase 1)Ended earlyNCT01186328
What this trial is testing

EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Lymphoblastic Leukemia, AcuteLymphoblastic Leukemia, Acute, ChildhoodLeukemia, Lymphoblastic, Acute, T Cell+1 more
Therapeutic Advances in Childhood Leukemia Consortium 6
Not applicableStudy completedNCT00049465
What this trial is testing

Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00089011
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+171 more
Fred Hutchinson Cancer Center 150
Early research (Phase 1)Study completedNCT00004101
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT02650999
What this trial is testing

Pembrolizumab in Patients Failing to Respond to or Relapsing After CAR T Cell Therapy for Relapsed or Refractory Lymphomas

Who this might be right for
CD19+ Diffuse Large B-cell LymphomasFollicular LymphomasMantle Cell Lymphomas
Abramson Cancer Center at Penn Medicine 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07162571
What this trial is testing

This is a Phase I/II Interventional, Open-label Treatment Study Designed to Evaluate the Safety and Efficacy of Anti CD 19/22 CAR- T Cells Immunotherapy for Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma.

Who this might be right for
Acute Lymphobkastic LeukemiaB Cell Lymphoma
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology 17
Early research (Phase 1)Looking for participantsNCT07572136
What this trial is testing

Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Who this might be right for
B-AllAcute Lymphoblastic Leukemia
National Cancer Institute (NCI) 57
Early research (Phase 1)Study completedNCT00504972
What this trial is testing

Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies

Who this might be right for
Non-Hodgkin's LymphomaChronic Lymphocytic Leukemia
Weill Medical College of Cornell University 23
Testing effectiveness (Phase 2)UnknownNCT03398967
What this trial is testing

A Feasibility and Safety Study of Universal Dual Specificity CD19 and CD20 or CD22 CAR-T Cell Immunotherapy for Relapsed or Refractory Leukemia and Lymphoma

Who this might be right for
B Cell LeukemiaB Cell Lymphoma
Chinese PLA General Hospital 80
Early research (Phase 1)Ended earlyNCT00800150
What this trial is testing

Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
City of Hope Medical Center 6
Testing effectiveness (Phase 2)WithdrawnNCT00093314
What this trial is testing

HuMax-CD20 in Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT00073918
What this trial is testing

Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaCutaneous B-cell Non-Hodgkin LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+14 more
Fred Hutchinson Cancer Center 111
Testing effectiveness (Phase 2)Looking for participantsNCT06045910
What this trial is testing

A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, Large B-Cell, DiffuseLymphoma, Mantle-Cell+3 more
Cancer Research UK 84
Next Page